drugset / Trial / NCT02450773
Prevention of Severe Postpartum Hypertension
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine whether postpartum administration of furosemide to women with antepartum hypertensive disorders (gestational hypertension, preeclampsia) or elevated blood pressure in the first 24 hours following delivery reduces severe postpartum hypertension.
Timeline
- Start
- 2015-08
- Primary completion
- 2022-05
- Completion
- 2022-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Furosemide | Other / unclassified | 40 mg | — |
| Background | Potassium Chloride | Small molecule | 20 meq | — |